Dianthus TherapeuticsDNTH
13F holders, Q2 2026 (June 30)269holders +28
59new positions
32sold out
6famous investors
$97.31avg. 13F price*
At the end of Q2 2026, 269 institutions reported holding Dianthus Therapeutics Inc. (DNTH) in their 13F filings, up 28 from Q1 2026. 59 opened new positions and 32 sold out. The largest holders were FMR LLC ($799.3M), BlackRock, Inc. ($402.0M) and T. Rowe Price Investment Management, Inc. ($379.0M). 6 famous investors held it, including Ken Griffin (0.1% of Citadel Advisors's portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Dianthus Therapeutics Inc.
- CUSIP
- 252828108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 59 | $198.4M |
| Exits | 32 | $412.6M |
All 13F filers, Q1 2026 → Q2 2026: 13,696,473 shares bought and 10,158,948 shares sold, net +3,537,525 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 269 holders
| FMR LLC | 0.03% | Add +5.6% | 8,199,893 | $799.3M |
| BlackRock, Inc. | 0.01% | Add +29.9% | 4,123,822 | $402.0M |
| T. Rowe Price Investment Management, Inc. | 0.25% | Add +200.9% | 3,888,456 | $379.0M |
| Wellington Management Group LLP | 0.05% | Add +24.4% | 3,229,882 | $314.8M |
| Fairmount Funds Management LLC | 16.35% | No change | 2,537,191 | $247.3M |
| T. Rowe Price Associates Inc. | 0.02% | Add +119.3% | 2,514,946 | $245.2M |
| State Street Corp. | 0.01% | Add +68.5% | 2,357,440 | $229.8M |
| Vanguard Capital Management LLC | 0.00% | Add +6.3% | 2,159,568 | $210.5M |
| Avidity Partners Management LP | 32.85% | No change | 2,104,184 | $205.1M |
| Octagon Capital Advisors LP | 16.48% | Reduce -5.4% | 1,841,667 | $179.5M |
| TCG Crossover Management, LLC | 3.93% | No change | 1,676,624 | $163.4M |
| Fred Alger Management, LLC | 0.42% | Add +12.1% | 1,302,493 | $127.0M |
| Geode Capital Management, LLC | 0.01% | Add +37.4% | 1,258,502 | $122.7M |
| Venrock Adviser, LLC | 3.49% | No change | 1,180,000 | $115.0M |
| UBS Group AG | 0.02% | Add +46.0% | 1,140,260 | $111.2M |
| Deerfield Management Company, L.P. | 1.37% | Add +10.3% | 1,125,313 | $109.7M |
| Jennison Associates LLC | 0.06% | Add +110.6% | 1,021,763 | $99.6M |
| Polar Capital Holdings Plc | 0.28% | Reduce -5.3% | 1,018,726 | $99.3M |
| Citadel Advisors | 0.06% | Reduce -39.5% | 974,911 | $95.0M |
| Franklin Resources Inc. | 0.02% | Add +0.1% | 968,983 | $94.5M |
| Baker Bros. Advisors LP | 0.42% | No change | 852,164 | $83.1M |
| Logos Global Management LP | 3.36% | Add +100.0% | 800,000 | $78.0M |
| Cormorant Asset Management, LP | 3.75% | Reduce -21.1% | 750,000 | $73.1M |
| Alliancebernstein L.P. | 0.02% | Reduce -9.9% | 834,150 | $70.0M |
| Braidwell LP | 2.23% | Reduce -33.9% | 594,562 | $58.0M |
| Vanguard Portfolio Management LLC | 0.00% | Add +63.2% | 570,115 | $55.6M |
| Ameriprise Financial Inc. | 0.01% | Add +24.0% | 531,999 | $51.9M |
| Woodline Partners LP | 0.15% | Add +15.5% | 500,548 | $48.8M |
| Barclays PLC | 0.01% | Add +13.7% | 431,753 | $42.1M |
| Lord, Abbett & Co. LLC | 0.12% | Add +41.1% | 422,185 | $41.2M |
| MPM Bioimpact LLC | 2.50% | Reduce -0.9% | 420,002 | $40.9M |
| Northern Trust Corp. | 0.00% | Add +35.6% | 411,791 | $40.1M |
| Affinity Asset Advisors, LLC | 1.94% | Add +14.3% | 400,000 | $39.0M |
| Silverarc Capital Management, LLC | 4.23% | Reduce -40.4% | 390,000 | $38.0M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -30.3% | 382,161 | $37.3M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +19.8% | 365,963 | $35.7M |
| Bain Capital Life Sciences Investors, LLC | 2.10% | No change | 362,470 | $35.3M |
| Spruce Street Capital LP | 6.79% | Reduce -4.9% | 354,816 | $34.6M |
| Vivo Capital, LLC | 3.15% | No change | 353,998 | $34.5M |
| Dimensional Fund Advisors LP | 0.01% | Reduce -1.2% | 321,503 | $31.3M |
| Westfield Capital Management Co. LP | 0.10% | New | 314,914 | $30.7M |
| Vanguard Fiduciary Trust Co. | 0.01% | Add +21.1% | 302,482 | $29.5M |
| Driehaus Capital Management LLC | 0.17% | Reduce -7.0% | 295,266 | $28.8M |
| First Turn Management, LLC | 2.98% | Add +29.4% | 285,771 | $27.9M |
| Assenagon Asset Management S.A. | 0.04% | New | 280,649 | $27.4M |
| Tang Capital Management LLC | 1.18% | No change | 264,692 | $25.8M |
| Artisan Partners Limited Partnership | 0.04% | Reduce -32.4% | 258,269 | $25.2M |
| Bank of America Corp. | 0.00% | Add +36.0% | 256,833 | $25.0M |
| Bank of New York Mellon Corp | 0.00% | Add +36.1% | 256,393 | $25.0M |
| RTW Investments, LP | 0.21% | No change | 248,063 | $24.2M |
| Emerald Advisers, LLC | 0.57% | New | 247,805 | $24.2M |
| Pictet Asset Management Holding SA | 0.02% | Add +4922.2% | 247,295 | $24.1M |
| TD Asset Management Inc | 0.02% | Add +93.3% | 225,334 | $22.0M |
| Eventide Asset Management, LLC | 0.29% | No change | 225,261 | $22.0M |
| LMR Partners LLP | 0.20% | Add +92.4% | 223,995 | $21.8M |
| Candriam S.C.A. | 0.09% | Reduce -4.4% | 204,214 | $19.9M |
| Stempoint Capital LP | 3.39% | Add +134.9% | 200,851 | $19.6M |
| Qube Research & Technologies Ltd | 0.02% | Add +548.8% | 196,924 | $19.2M |
| Samlyn Capital, LLC | 0.32% | Reduce -54.5% | 196,326 | $19.1M |
| Nicholas Investment Partners, LP | 1.17% | Add +264.4% | 186,769 | $18.2M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Add +15.6% | 185,000 | $18.0M |
| Ensign Peak Advisors, Inc | 0.03% | Reduce -14.8% | 174,187 | $17.0M |
| TimesSquare Capital Management, LLC | 0.24% | New | 166,357 | $16.2M |
| Atika Capital Management LLC | 1.60% | Add +28.1% | 165,000 | $16.1M |
| Artia Global Partners LP | 3.02% | No change | 162,990 | $15.9M |
| Balyasny Asset Management L.P. | 0.03% | Reduce -65.8% | 162,005 | $15.8M |
| Neuberger Berman Group LLC | 0.01% | Add +166.7% | 157,574 | $15.4M |
| Alyeska Investment Group, L.P. | 0.04% | Add +188.2% | 150,592 | $14.7M |
| Russell Investments Group, Ltd. | 0.01% | Add +11.1% | 143,431 | $14.0M |
| Eagle Health Investments LP | 2.12% | New | 131,344 | $12.8M |
| Emerald Mutual Fund Advisers Trust | 0.45% | New | 131,018 | $12.8M |
| Marshall Wace, LLP | 0.01% | Reduce -62.4% | 128,743 | $12.5M |
| PFM Health Sciences, LP | 1.03% | Reduce -29.6% | 121,222 | $11.8M |
| Tri Locum Partners LP | 1.45% | Reduce -17.1% | 120,712 | $11.8M |
| Nuveen, LLC | 0.00% | Reduce -45.1% | 119,460 | $11.6M |
| Orbimed Advisors LLC | 0.21% | New | 115,000 | $11.2M |
| Patient Square Capital LP | 1.63% | Add +15.0% | 108,000 | $10.5M |
| Two Sigma Investments, LP | 0.01% | New | 107,455 | $10.5M |
| Morgan Stanley | 0.00% | Add +9.2% | 106,376 | $10.4M |
| Seven Grand Managers, LLC | 0.39% | No change | 100,000 | $9.7M |
| First Trust Advisors LP | 0.01% | New | 94,152 | $9.2M |
| Sei Investments Co. | 0.01% | Add +0.1% | 92,280 | $9.0M |
| Millennium Management | 0.01% | Reduce -64.9% | 91,838 | $9.0M |
| Victory Capital Management Inc. | 0.00% | Add +463.9% | 88,315 | $8.6M |
| American Century Companies Inc. | 0.00% | Add +11.1% | 87,860 | $8.6M |
| Rhenman & Partners Asset Management AB | 0.79% | Add +5.5% | 86,127 | $8.4M |
| Invesco Ltd. | 0.00% | Reduce -34.5% | 85,603 | $8.3M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +24.8% | 75,396 | $7.3M |
| Moody Aldrich Partners LLC | 1.31% | Reduce -9.2% | 74,552 | $7.3M |
| Swiss National Bank | 0.00% | Add +7.0% | 73,800 | $7.2M |
| Deutsche Bank AG | 0.00% | Add +121.7% | 69,756 | $6.8M |
| Mercer Global Advisors Inc. | 0.01% | New | 65,683 | $6.4M |
| LPL Financial LLC | 0.00% | Add +59.9% | 65,295 | $6.4M |
| Seven Fleet Capital Management LP | 1.04% | Add +19.3% | 64,723 | $6.3M |
| SummitTX Capital, L.P. | 0.16% | Reduce -36.2% | 63,866 | $6.2M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -3.7% | 62,829 | $6.1M |
| New York State Common Retirement Fund | 0.01% | Add +25.2% | 60,048 | $5.9M |
| Sio Capital Management, LLC | 0.99% | Reduce -84.0% | 59,254 | $5.8M |
| Rhumbline Advisers | 0.00% | Add +29.5% | 58,521 | $5.7M |
| Jones Hill Capital LP | 1.18% | New | 57,100 | $5.6M |
"% of holder's portfolio" is DNTH's weight in each manager's 13F, not the share of Dianthus Therapeutics Inc. the manager owns.